Previous 10 | Next 10 |
SAN FRANCISCO , Sept. 11, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Kimber Lockhart to its Board of Directors, effective September 10, 2020 . "We are excited to welcome Kimber Loc...
SOUTH PLAINFIELD, N.J. , Sept. 9, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new program that provides genetic testing and counseling for people who may have a neurotransmitter disorder, such as aromatic L-amino acid decarboxylase (AADC) deficiency....
Invitae ( NVTA ) is at the forefront of the genetic testing industry. The company is part of a growing effort to push genetics into mainstream medicine. While genetics is still an emerging field, it is one of the most promising in medicine. Invitae is capitalizing on the convergence of technol...
SAN FRANCISCO , Sept. 3, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced enrollment has begun for a nationwide study to better understand the role of current genetic testing guidelines in ensuring prostate cancer patients rece...
SAN FRANCISCO , Sept. 1, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will virtually participate in a fireside chat at the 18th Annual Morgan Stanley Global Healthcare Conference on ...
The COVID-19 pandemic threw a huge wrench in Invitae 's (NYSE: NVTA) growth plans. In 2019, the genetic test maker's sales volumes grew by nearly 60%. In the second quarter of 2020, its volume growth was just 8%. Requests for tests for immediate issues -- in reproductive health line, for ins...
The following slide deck was published by Invitae Corporation in conjunction with their 2020 Q2 earnings Read more ...
Vapotherm (NYSE: VAPO ) -26% on Q2 earnings . More news on: Vapotherm, Inc., New Relic, Inc., Alterity Therapeutics Limited, Stocks on the move, , Read more ...
Image source: The Motley Fool. Invitae (NYSE: NVTA) Q2 2020 Earnings Call Aug 04, 2020 , 4:30 p.m. ET Operator Continue reading
Invitae Corporation (NVTA) Q2 2020 Earnings Conference Call August 4, 2020 4:30 PM ET Company Participants Laura D'Angelo – Head of Investor Relations Sean George – Chief Executive Officer Shelly Guyer – Chief Financial Officer Lee Bendekgey – Chief ...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...